Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fengxi Liu

Showing results (21-30 of 23) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 23 results.
Materials Today. Bio|July 18, 2025
Biomimetic tumor cell membrane-camouflaged nanomicelles for synergistic chemo-immunotherapy of Triple-negative breast cancerXiaoman Xu, Yunmei Song, Mingli Li, et al.
Frontiers in Pharmacology|September 13, 2024
Interaction between tacrolimus and calcium channel blockers based on CYP3A5 genotype in Chinese renal transplant recipientsHuiying Zong, Yundi Zhang, Fengxi Liu, et al.
Bioorganic & Medicinal Chemistry Letters|December 24, 2013
Design, synthesis and in vitro cytotoxicity evaluation of 5-(2-carboxyethenyl)isatin derivatives as anticancer agentsKailin Han, Yao Zhou, Fengxi Liu, et al.
Pageof 3

Showing results (21-30 of 23) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 23 results.
Materials Today. Bio|July 18, 2025
Biomimetic tumor cell membrane-camouflaged nanomicelles for synergistic chemo-immunotherapy of Triple-negative breast cancerXiaoman Xu, Yunmei Song, Mingli Li, et al.
Frontiers in Pharmacology|September 13, 2024
Interaction between tacrolimus and calcium channel blockers based on CYP3A5 genotype in Chinese renal transplant recipientsHuiying Zong, Yundi Zhang, Fengxi Liu, et al.
Bioorganic & Medicinal Chemistry Letters|December 24, 2013
Design, synthesis and in vitro cytotoxicity evaluation of 5-(2-carboxyethenyl)isatin derivatives as anticancer agentsKailin Han, Yao Zhou, Fengxi Liu, et al.
Pageof 3